Evaluation of Prescription Adaptation Following Changes to A Provincial Drug Insurance Formulary
On 1 December 2016, British Columbia’s (BC) provincial drug insurance program changed which medications in certain classes would benefit under the insurance program in an attempt to reduce expenditure. As part of the modernization, HMG-CoA reductase inhibitors (Statins), Angiotensin conver...
Saved in:
Main Author: | Robert T. Pammett (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Blockchains, Formulary Evaluations and Health Technology Assessment
by: Paul Langley, et al.
Published: (2018) -
Neonatal Drug Formularies-A Global Scope
by: Dotan Shaniv, et al.
Published: (2023) -
Formulary Reconciliation: Implementation of a Comprehensive Approach to Formulary Maintenance and Standardization
by: Janine G. Martino PharmD, BCOP, APh, et al.
Published: (2024) -
Influence of Hospital Formularies on Outpatient Prescribing Practices: Analysis of the Introduction of a Local Formulary: A Single-Center, 2-Year Follow-Up, Retrospective Cohort Study of a Local Formulary in Japan
by: Norihito Kanai PhD, et al.
Published: (2022) -
Creative Destruction: Next Generation Sequencing in Drug Development, Formulary Evaluations and Pricing
by: Paul C Langley
Published: (2016)